553 related articles for article (PubMed ID: 9199297)
1. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
Nakshatri H; Bhat-Nakshatri P; Martin DA; Goulet RJ; Sledge GW
Mol Cell Biol; 1997 Jul; 17(7):3629-39. PubMed ID: 9199297
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
4. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
6. Establishment of hormone-dependent and hormone-independent carcinoma cell lines with different metastatic potentials from spontaneous mammary tumors in aged Wistar rats.
Nakanishi H; Taylor RM; Hawkins AL; Griffin CA; Martin GR; Passaniti A
Int J Cancer; 1994 Aug; 58(4):592-601. PubMed ID: 8056457
[TBL] [Abstract][Full Text] [Related]
7. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.
Biswas DK; Dai SC; Cruz A; Weiser B; Graner E; Pardee AB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10386-91. PubMed ID: 11517301
[TBL] [Abstract][Full Text] [Related]
8. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
Rabi T; Huwiler A; Zangemeister-Wittke U
Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
[TBL] [Abstract][Full Text] [Related]
9. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
Nathan S; Ma Y; Tomita YA; De Oliveira E; Brown ML; Rosen EM
Breast Cancer Res Treat; 2017 Dec; 166(3):681-693. PubMed ID: 28808806
[TBL] [Abstract][Full Text] [Related]
10. Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.
Pratt MA; Bishop TE; White D; Yasvinski G; Ménard M; Niu MY; Clarke R
Mol Cell Biol; 2003 Oct; 23(19):6887-900. PubMed ID: 12972607
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
Sliva D; Rizzo MT; English D
J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
14. Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway.
Zhou JN; Ljungdahl S; Shoshan MC; Swedenborg J; Linder S
Mol Carcinog; 1998 Apr; 21(4):234-43. PubMed ID: 9585253
[TBL] [Abstract][Full Text] [Related]
15. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
[TBL] [Abstract][Full Text] [Related]
17. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
Dong G; Chen Z; Kato T; Van Waes C
Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
19. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
Bendinelli P; Matteucci E; Maroni P; Desiderio MA
Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
